Fuan Pharmaceutical(300194.SZ)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
Fuan Pharmaceutical
300194.SZ
Fuan Pharmaceutical (Group) Co., Ltd., together with its subsidiaries, research and develops, produces, and sells chemical drugs in the People's Republic of China. It offers APIs; intermediates; and FFPs, such as anti-tumor, generic drugs, antibiotics and oral, as well as freeze-drying preparation for injection. The company was formerly known as Chongqing Fuan Pharmaceutical (Group) Co., Ltd. and changed its name to Fuan Pharmaceutical (Group) Co., Ltd.
2.805 T
300194.SZMarket value -Rank by Market Cap -/-

Financial Score

19/05/2026 Update
D
PharmaceuticalsIndustry
Industry Ranking195/215
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE0.00%D
    • Profit Margin0.00%D
    • Gross Margin40.58%B
  • Growth ScoreE
    • Revenue YoY-18.13%E
    • Net Profit YoY-72.23%E
    • Total Assets YoY-7.34%E
    • Net Assets YoY-0.50%D
  • Cash ScoreC
    • Cash Flow Margin588.36%A
    • OCF YoY-18.13%E
  • Operating ScoreE
    • Turnover0E
  • Debt ScoreA
    • Gearing Ratio21.44%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Fuan Pharmaceutical released its performance for the first three quarters, with a net profit attributable to the parent company of 166 million yuan, a decrease of 44.87%

    Zhitong·
    SZ
    300194
    -1.25%
    Zhitong·
    SZ
    300194
    -1.25%

    Fuan Pharmaceutical Announcement on the Implementation of the 2025 Half-Year Equity Distribution Plan

    Zhitong·
    SZ
    300194
    -1.25%
    Zhitong·
    SZ
    300194
    -1.25%

    Fuan Pharmaceutical released its performance for the first half of the year, with a net profit attributable to the parent company of 113 million yuan, a decrease of 47.74%

    Zhitong·
    SZ
    300194
    -1.25%
    Zhitong·
    SZ
    300194
    -1.25%

    Asian Market Highlights: Penny Stocks To Watch In August 2025

    Simplywall·
    HK
    00691
    0.00%
    SZ
    300194
    -1.25%
    Simplywall·
    HK
    00691
    0.00%
    SZ
    300194
    -1.25%

    The chemical pharmaceutical sector sees a short-term surge, with Fuan Pharmaceutical rising over 10%

    Zhitong·
    SZ
    300194
    -1.25%
    Zhitong·
    SZ
    300194
    -1.25%
    © 2026 Longbridge｜Disclaimer